Bag This Bargain Even Cheaper Than Chief Commercial Officer Yarema Did
July 07, 2021 at 10:04 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on June 14, Atara Biotherapeutics Inc's Chief Commercial Officer, Kristin Yarema, invested $500,369.64 into 34,354 shares of ATRA, for a cost per share of $14.57..